Comité del programa
-
Kazuhiro Kanmuri, PHD Executive Officer, Head of Development Div.
Tanabe Pharma Corporation, Japan -
Hirotaka Inoue, PHD, MBA Head, Leading Changes Office, Enterprise Transformation
GlaxoSmithKline K.K., Japan -
Daisuke Kajiwara, PHD Director, Enterprise Solution dept.
Cytiva, Japan -
Goshi Ozawa, MS CEO
Real Discovery Outdorrs K.K., Japan -
Koichiro Yuji, MD, PHD, FACP Project Associate Professor, The Institute of Medical Science
Japan
¿Tiene una cuenta?